Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

MEI Pharma Q2 2024 GAAP EPS $(1.66) Misses $(1.32) Estimate

Author: Benzinga Newsdesk | February 13, 2024 06:08pm

MEI Pharma (NASDAQ:MEIP) reported quarterly losses of $(1.66) per share which missed the analyst consensus estimate of $(1.32) by 25.76 percent.

Posted In: MEIP